Eli Lilly and Company

Historical 13F Holders

Symbol
LLY
CUSIP
532457108
All holders as of
Q3 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q3 4,089 774 M $590 B
2025 Q2 4,111 787 M $612 B
2025 Q1 4,100 825 M $680 B
2024 Q4 4,077 781 M $602 B
2024 Q3 3,833 809 M $704 B
2024 Q2 3,750 813 M $736 B
2024 Q1 3,642 826 M $641 B
2023 Q4 3,428 821 M $479 B
2023 Q3 3,118 787 M $424 B
2023 Q2 2,948 786 M $367 B
2023 Q1 2,736 843 M $271 B
2022 Q4 2,788 827 M $304 B
2022 Q3 2,611 799 M $259 B
2022 Q2 2,556 789 M $256 B
2022 Q1 2,442 792 M $227 B
2021 Q4 2,407 792 M $219 B
2021 Q3 2,159 792 M $183 B
2021 Q2 2,123 794 M $182 B
2021 Q1 2,036 793 M $148 B
2020 Q4 1,982 795 M $135 B
2020 Q3 1,864 736 M $109 B
2020 Q2 1,862 743 M $122 B
2020 Q1 1,779 753 M $104 B
2019 Q4 1,771 759 M $99.7 B
2019 Q3 1,615 746 M $83.5 B
2019 Q2 1,612 759 M $84.0 B
2019 Q1 1,711 783 M $101 B
2018 Q4 1,660 841 M $97.2 B
2018 Q3 1,533 848 M $90.9 B
2018 Q2 1,457 847 M $72.2 B
2018 Q1 1,419 845 M $65.4 B
2017 Q4 1,466 861 M $72.6 B
2017 Q3 1,308 851 M $72.7 B
2017 Q2 1,327 843 M $69.4 B
2017 Q1 1,349 847 M $71.2 B
2016 Q4 1,320 837 M $61.5 B
2016 Q3 1,264 836 M $67.1 B
2016 Q2 1,253 838 M $66.1 B
2016 Q1 1,219 849 M $59.9 B
2015 Q4 1,296 857 M $72.2 B
2015 Q3 1,204 852 M $71.5 B
2015 Q2 1,204 847 M $70.7 B
2015 Q1 1,164 843 M $61.3 B
2014 Q4 1,198 851 M $59.0 B
2014 Q3 1,111 840 M $54.6 B
2014 Q2 1,099 859 M $54.6 B
2014 Q1 1,097 836 M $49.6 B